Cargando…
Breast cancer risk in premalignant lesions: osteopontin splice variants indicate prognosis
BACKGROUND: Premalignant breast lesions pose variable risks for transformation, raising the question who should receive treatment to counteract the potential progression to breast cancer. Because the secreted metastasis mediator Osteopontin (OPN) is a marker for breast cancer aggressiveness, its pre...
Autores principales: | Walaszek, Kinga, Lower, Elyse E., Ziolkowski, Piotr, Weber, Georg F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6251032/ https://www.ncbi.nlm.nih.gov/pubmed/30353046 http://dx.doi.org/10.1038/s41416-018-0228-1 |
Ejemplares similares
-
Breast cancer risk in papilloma patients: Osteopontin splice variants indicate prognosis
por: Ziółkowski, Piotr, et al.
Publicado: (2022) -
Osteopontin splice variants are differential predictors of breast cancer treatment responses
por: Zduniak, Krzysztof, et al.
Publicado: (2016) -
Meta-analysis of Osteopontin splice variants in cancer
por: An, Yu, et al.
Publicado: (2023) -
RNA blood levels of osteopontin splice variants are cancer markers
por: Hartung, Franz, et al.
Publicado: (2013) -
Expression of Oct4A splicing variant in human bladder premalignant lesions predicts its invasiveness
por: Jóźwicki, Wojciech, et al.
Publicado: (2012)